Targeted screening for hereditary haemochromatosis in high-risk groups
Treatment of acute hepatitis C with interferon α-2b
Metformin in the treatment of non-alcoholic steatohepatitis
Pharmacokinetic variations of acetaminophen according to liver dysfunction and portal hypertension status
Pegylated interferon-α2a kinetics during experimental haemodialysis
Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese
Therapeutic Arthritis Research and Gastrointestinal Event Trial of lumiracoxib – study design and patient demographics
Azathioprine dose escalation in inflammatory bowel disease
Risk of vascular disease in adults with diagnosed coeliac disease
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn
The Visceral Sensitivity Index
Seven-day therapy for Helicobacter pylori in the United States
13C-ethanol breath test reveals impaired alcohol metabolism in patients with Helicobacter pylori infection
Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication
Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C
The treatment algorithm instead of the unknown optimal dose of botulinum toxin for chronic anal fissure
The treatment algorithm instead of the unknown optimal dose of botulinum toxin for chronic anal fissure